nitrofurantoin has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brima, W; Lang, V; O'Connor, RA; Patel, V | 1 |
Chadha, A; Gandotra, SD; Patel, DB; Smotrys, MA | 1 |
Cohee, BM; Forster, CJ; Hartzell, JD; Wood-Morris, RN | 1 |
Bag, S; Ganesamoni, R; Kumar, S; Mandal, AK; Singh, SK; Taneja, N | 1 |
4 other study(ies) available for nitrofurantoin and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Systemic Inflammatory Response Syndrome from Nitrofurantoin: A Case Report.
Topics: Aged; Anti-Bacterial Agents; Female; Fever; Humans; Leukocytosis; Nitrofurantoin; Systemic Inflammatory Response Syndrome | 2022 |
Systemic inflammatory response syndrome (SIRS) and a left bundle branch block (LBBB) due to nitrofurantoin.
Topics: Aged; Anti-Infective Agents, Urinary; Bundle-Branch Block; Female; Humans; Nitrofurantoin; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2017 |
Nitrofurantoin-induced systemic inflammatory response syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Escherichia coli Infections; Gram-Negative Bacterial Infections; Humans; Male; Nitrofurantoin; Stenotrophomonas; Systemic Inflammatory Response Syndrome; Urinary Bladder Neoplasms | 2009 |
Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Endotoxemia; Female; Humans; Logistic Models; Male; Middle Aged; Nephrostomy, Percutaneous; Nitrofurantoin; Prospective Studies; Risk Factors; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2012 |